Literature DB >> 19629019

Spontaneous resolution of macular edema after panretinal photocoagulation in florid proliferative diabetic retinopathy.

David Gaucher1, Pina Fortunato, Amélie LeCleire-Collet, Tristan Bourcier, Claude Speeg-Schatz, Ramin Tadayoni, Pascale Massin.   

Abstract

PURPOSE: To report the evolution of diabetic macular edema (DME) after extensive panretinal photocoagulation in patients with Type 1 diabetes exhibiting florid proliferative diabetic retinopathy (FPDR).
METHODS: This retrospective observational case series comprised 17 eyes of 10 consecutive patients (8 women and 2 men). All patients exhibited FPDR combined with severe DME, and all underwent panretinal photocoagulation. The evolution of visual acuity and progression of FPDR were evaluated. The evolution of DME during follow-up was assessed by fluorescein angiography and repeated optical coherence tomography examinations.
RESULTS: At baseline, all eyes had diffuse DME. Mean logMAR visual acuity was 0.402 +/- 0.46. Mean central macular thickness was 468.23 +/- 113.63 microm. After panretinal photocoagulation, DME regressed spontaneously in all eyes after a mean follow-up of 7.1 +/- 2.68 months. Mean central macular thickness decreased to 268.12 +/-54.67 microm (t-test, P < 0.0001). Mean visual acuity improved significantly to 0.184 +/- 0.12 (t-test, P = 0.048). Diabetic macular edema only recurred in two eyes.
CONCLUSION: In DME combined with FPDR, extensive panretinal photocoagulation and glycemic control seem effective in reducing DME and improving vision. In FPDR, DME may be caused by excessive production of vascular endothelial growth factor by the unperfused retina.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629019     DOI: 10.1097/IAE.0b013e3181a91e9f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

Review 1.  Screening, prevention, and ambitious management of diabetic macular edema in patients with type 1 diabetes.

Authors:  Ryan M Tarantola; Raj K Maturi; Shalesh Kushal; Sunil Gupta
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

2.  Multicolor pattern scan laser for diabetic retinopathy with cataract.

Authors:  Takao Hirano; Yasuhiro Iesato; Toshinori Murata
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

3.  Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.

Authors:  Andreas Ebneter; Sebastian Wolf; Martin S Zinkernagel
Journal:  Br J Ophthalmol       Date:  2015-07-17       Impact factor: 4.638

4.  Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy.

Authors:  Murtaza Sameen; Muhammad Saim Khan; Ahsan Mukhtar; Muhammad Amer Yaqub; Mazhar Ishaq
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

5.  Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept.

Authors:  Ahmad M Mansour; Khalil El Jawhari; J Fernando Arevalo
Journal:  Clin Ophthalmol       Date:  2019-04-18

6.  Factors associated with visual recovery after sub-Tenon injection of triamcinolone acetonide in diabetic macular edema.

Authors:  Hiroko Kawashima; Kenichi Mizukawa; Junichi Kiryu
Journal:  Clin Ophthalmol       Date:  2012-08-10

7.  Advances in retinal imaging for diabetic retinopathy and diabetic macular edema.

Authors:  Colin Siang Hui Tan; Milton Cher Yong Chew; Louis Wei Yi Lim; Srinivas R Sadda
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

8.  Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy.

Authors:  Ahsan Mukhtar; Muhammad Saim Khan; Murtaza Junejo; Mazhar Ishaq; Bushra Akbar
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.